Mural Oncology Reveals Final Cash Payment Due Upon Acquisition Completion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 26 2025
0mins
Transaction Agreement Details: Mural Oncology (MURA) has finalized the Additional Price Per Share as $0.000, leading to a total cash consideration of $2.035 per share for Mural shareholders upon closing of the Acquisition.
Acquisition Overview: The Acquisition involves XOMA Royalty Corporation acquiring the entire issued share capital of Mural through a scheme sanctioned by the Irish High Court, expected to close in early December 2025.
Parties Involved: The transaction is between Mural Oncology, XOMA Royalty Corporation, and XRA 5 Corp., with XOMA's subsidiary set to execute the acquisition.
Regulatory Approval: The completion of the Acquisition is contingent upon meeting outstanding closing conditions and receiving approval from the Irish High Court.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy XOMA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on XOMA
Wall Street analysts forecast XOMA stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 42.620
Low
50.00
Averages
71.00
High
97.00
Current: 42.620
Low
50.00
Averages
71.00
High
97.00
About XOMA
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's commercial assets include OJEMDA (tovorafenib), IXINITY, XACIATO, VABYSMO (faricimab svoa), DSUVIA (sufentanil sublingual tablet), and MIPLYFFA (arimoclomol). Its Phase III assets include Rilvegostomig (AZD2936), Ficlatuzumab (AV-299), Ovaprene, D-Fi (FCX-007), Seralutinib, Cetrelimab (JNJ-63723283), Ersodetug (RZ358), and Mezagitamab (TAK-079). Its Phase II assets include Acimtamig (AFM13), AFM24, Vosaroxin, Aldoxorubicin, G03-52-01, PBF-680, PBF-677, Vidutolimod (CMP-001), and RZ-402. Its others assets include COM902 and MT-0169.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating XOMA Royalty Corporation, Payoneer Global Inc., Fox Corporation, and National Storage Affiliates Trust for potential violations of federal securities laws and breaches of fiduciary duties that may affect shareholder rights.
- XOMA Transaction: XOMA Royalty Corporation is being sold to Ligand Pharmaceuticals for $39.00 per share, and Halper Sadeh LLC may seek increased compensation and additional disclosures for shareholders, potentially impacting their financial outcomes.
- Payoneer Sale: Payoneer Global Inc. is being sold for $7.40 per share in cash, with Halper Sadeh LLC encouraging Payoneer shareholders to reach out to understand their rights and options, which could significantly affect shareholder financial interests.
- Fox Merger: The merger between Fox Corporation and Roku, Inc. is expected to result in Fox shareholders owning approximately 73% of the combined entity, prompting Halper Sadeh LLC to potentially seek enhanced shareholder benefits and transparency in the transaction.
See More
Monteverde Law Firm Investigates Payoneer and Other Company Transactions
- Payoneer Investigation: Monteverde & Associates is investigating Payoneer Global Inc.'s sale to Nuvei, with shareholders expected to receive $7.40 per share in cash, potentially impacting shareholder returns significantly.
- Fox Merger Case: The merger between Fox Corporation and Roku, Inc. is expected to result in Fox shareholders owning approximately 73% of the combined entity, which could reshape the competitive landscape in the media industry.
- XOMA Shareholder Vote: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will provide shareholders with $39.00 per share in cash, with the shareholder vote scheduled for July 13, 2026, potentially influencing the company's future direction.
- National Storage Trust Transaction: The sale of National Storage Affiliates Trust to Public Storage will allow shareholders to receive 0.14 shares of Public Storage common stock for each National Storage share, with the shareholder vote set for July 14, 2026, which may affect market share dynamics.
See More
XOMA Announces Cash Dividends and Redemption Plan
- Cash Dividend Announcement: XOMA's Board has authorized cash dividends for holders of 8.625% Series A and 8.375% Series B Preferred Stock, with A shares receiving $0.53906 and B shares $0.52344, reflecting the company's commitment to shareholder returns.
- Redemption Plan: All outstanding Preferred Stock will be redeemed on July 14, 2026, at a price of $25.00 per share, which is expected to impact the company's capital structure and reduce future dividend expenditures.
- Merger Progress: The redemption is linked to the pending merger with Flex Merger Sub, Inc., indicating that the company is actively pursuing strategic integration that may enhance its competitive position in the market.
- Additional Rights Distribution: XOMA will also distribute contingent value rights to common stockholders on July 13, 2026, further enhancing shareholder value and demonstrating strategic considerations in the merger process.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Targeted Companies: Halper Sadeh LLC is investigating Avanos Medical, Inc., Nuvalent, Inc., XOMA Royalty Corporation, and TruBridge, Inc. for potential violations of federal securities laws or breaches of fiduciary duties, including Avanos's sale to American Industrial Partners for $25.00 per share.
- Shareholder Rights: Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options, with the firm offering to handle matters on a contingent fee basis, emphasizing its commitment to protecting shareholder interests.
- Potential Benefits: The investigation may lead to increased consideration or additional disclosures for shareholders, indicating Halper Sadeh LLC's dedication to securing better financial outcomes and transparency for investors.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, focusing on securities fraud and corporate misconduct cases, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Taylor Morrison Home Corp. by Berkshire Hathaway, with shareholders expected to receive $72.50 per share in cash, potentially providing significant financial returns for investors.
- Caesars Entertainment Transaction: In the deal with Fertitta Gaming Holdco, Caesars shareholders are anticipated to receive $31.00 per share in cash along with a ticking consideration, which could enhance shareholder returns over time.
- XOMA Shareholder Gains: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will see shareholders receiving $39.00 per share in cash, offering a clear and immediate financial benefit to investors.
- Avanos Medical Acquisition: Avanos Medical, Inc. is set to provide shareholders with $25.00 per share in cash from its sale to American Industrial Partners, with a shareholder vote scheduled for July 22, 2026, to finalize the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating Caesars Entertainment, Inc. (NASDAQ: CZR) for its sale to Fertitta Entertainment, Inc. at $31.00 per share in cash, potentially violating fiduciary duties and impacting shareholder rights.
- Potential Violations: The sale of XOMA Royalty Corporation (NASDAQ: XOMA) to Ligand Pharmaceuticals Incorporated for $39.00 per share is also under scrutiny, as it may limit superior competing offers, thereby harming shareholder interests.
- Legal Rights: LiveRamp Holdings, Inc. (NYSE: RAMP) is being sold to Publicis Groupe for $38.50 per share, and Halper Sadeh LLC encourages shareholders to reach out to understand their legal rights and options to ensure their interests are protected.
- Shareholder Protection: The transaction involving Taylor Morrison Home Corporation (NYSE: TMHC) selling to Berkshire Hathaway Inc. for $72.50 per common share in cash may lead Halper Sadeh LLC to seek increased compensation and additional disclosures to safeguard shareholder rights.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating XOMA Royalty Corporation, Payoneer Global Inc., Fox Corporation, and National Storage Affiliates Trust for potential violations of federal securities laws and breaches of fiduciary duties that may affect shareholder rights.
- XOMA Transaction: XOMA Royalty Corporation is being sold to Ligand Pharmaceuticals for $39.00 per share, and Halper Sadeh LLC may seek increased compensation and additional disclosures for shareholders, potentially impacting their financial outcomes.
- Payoneer Sale: Payoneer Global Inc. is being sold for $7.40 per share in cash, with Halper Sadeh LLC encouraging Payoneer shareholders to reach out to understand their rights and options, which could significantly affect shareholder financial interests.
- Fox Merger: The merger between Fox Corporation and Roku, Inc. is expected to result in Fox shareholders owning approximately 73% of the combined entity, prompting Halper Sadeh LLC to potentially seek enhanced shareholder benefits and transparency in the transaction.
See More
Monteverde Law Firm Investigates Payoneer and Other Company Transactions
- Payoneer Investigation: Monteverde & Associates is investigating Payoneer Global Inc.'s sale to Nuvei, with shareholders expected to receive $7.40 per share in cash, potentially impacting shareholder returns significantly.
- Fox Merger Case: The merger between Fox Corporation and Roku, Inc. is expected to result in Fox shareholders owning approximately 73% of the combined entity, which could reshape the competitive landscape in the media industry.
- XOMA Shareholder Vote: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will provide shareholders with $39.00 per share in cash, with the shareholder vote scheduled for July 13, 2026, potentially influencing the company's future direction.
- National Storage Trust Transaction: The sale of National Storage Affiliates Trust to Public Storage will allow shareholders to receive 0.14 shares of Public Storage common stock for each National Storage share, with the shareholder vote set for July 14, 2026, which may affect market share dynamics.
See More
XOMA Announces Cash Dividends and Redemption Plan
- Cash Dividend Announcement: XOMA's Board has authorized cash dividends for holders of 8.625% Series A and 8.375% Series B Preferred Stock, with A shares receiving $0.53906 and B shares $0.52344, reflecting the company's commitment to shareholder returns.
- Redemption Plan: All outstanding Preferred Stock will be redeemed on July 14, 2026, at a price of $25.00 per share, which is expected to impact the company's capital structure and reduce future dividend expenditures.
- Merger Progress: The redemption is linked to the pending merger with Flex Merger Sub, Inc., indicating that the company is actively pursuing strategic integration that may enhance its competitive position in the market.
- Additional Rights Distribution: XOMA will also distribute contingent value rights to common stockholders on July 13, 2026, further enhancing shareholder value and demonstrating strategic considerations in the merger process.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Targeted Companies: Halper Sadeh LLC is investigating Avanos Medical, Inc., Nuvalent, Inc., XOMA Royalty Corporation, and TruBridge, Inc. for potential violations of federal securities laws or breaches of fiduciary duties, including Avanos's sale to American Industrial Partners for $25.00 per share.
- Shareholder Rights: Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options, with the firm offering to handle matters on a contingent fee basis, emphasizing its commitment to protecting shareholder interests.
- Potential Benefits: The investigation may lead to increased consideration or additional disclosures for shareholders, indicating Halper Sadeh LLC's dedication to securing better financial outcomes and transparency for investors.
- Legal Advocacy: Halper Sadeh LLC represents investors globally, focusing on securities fraud and corporate misconduct cases, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Taylor Morrison Home Corp. by Berkshire Hathaway, with shareholders expected to receive $72.50 per share in cash, potentially providing significant financial returns for investors.
- Caesars Entertainment Transaction: In the deal with Fertitta Gaming Holdco, Caesars shareholders are anticipated to receive $31.00 per share in cash along with a ticking consideration, which could enhance shareholder returns over time.
- XOMA Shareholder Gains: XOMA Royalty Corporation's sale to Ligand Pharmaceuticals will see shareholders receiving $39.00 per share in cash, offering a clear and immediate financial benefit to investors.
- Avanos Medical Acquisition: Avanos Medical, Inc. is set to provide shareholders with $25.00 per share in cash from its sale to American Industrial Partners, with a shareholder vote scheduled for July 22, 2026, to finalize the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Focus: Halper Sadeh LLC is investigating Caesars Entertainment, Inc. (NASDAQ: CZR) for its sale to Fertitta Entertainment, Inc. at $31.00 per share in cash, potentially violating fiduciary duties and impacting shareholder rights.
- Potential Violations: The sale of XOMA Royalty Corporation (NASDAQ: XOMA) to Ligand Pharmaceuticals Incorporated for $39.00 per share is also under scrutiny, as it may limit superior competing offers, thereby harming shareholder interests.
- Legal Rights: LiveRamp Holdings, Inc. (NYSE: RAMP) is being sold to Publicis Groupe for $38.50 per share, and Halper Sadeh LLC encourages shareholders to reach out to understand their legal rights and options to ensure their interests are protected.
- Shareholder Protection: The transaction involving Taylor Morrison Home Corporation (NYSE: TMHC) selling to Berkshire Hathaway Inc. for $72.50 per common share in cash may lead Halper Sadeh LLC to seek increased compensation and additional disclosures to safeguard shareholder rights.
See More
